Platelet endothelial cell adhesion molecule-1 (PECAM-1) is a cell surface glycoprotein receptor expressed on a range of blood cells including platelets, and is also on vascular endothelial cells.
INTRODUCTION
Platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) is a 130kDa membrane glycoprotein that is expressed on a range of blood cells including platelets, monocytes, neutrophils, B lymphocytes, some T lymphocyte subsets, and also on vascular endothelial cells [1] [2] [3] [4] . This member of the immunoglobulin superfamily has been reported to be associated with a wide range of functions, depending on the cell of interest. These include transendothelial migration of leukocytes [5] [6] [7] , integrin regulation [8] [9] [10] [11] [12] [13] [14] [15] [16] , modulation of T and B lymphocyte antigen receptor signalling 17, 18 , B lymphocyte development 19 , vasculogenesis 20 , apoptosis 21, 22 and protection against endotoxic shock 23 .
Several lines of investigation have recently determined that PECAM-1 is involved in the negative regulation of platelet function in vitro. The activation of PECAM-1 prior to the stimulation of platelets results in the inhibition of platelet aggregation and the inhibition of activatory signalling mechanisms 24, 25 . Of particular note, therefore, are the observations that mouse platelets deficient in PECAM-1 are hyper-responsive to stimulation with collagen, and demonstrate enhanced aggregation, secretion and adhesion to this agonist 26 . Platelets from PECAM-1 deficient mice have also been shown to form larger thrombi in vitro under physiological flow conditions 25 .
PECAM-1 participates in homophilic ligand binding interactions [27] [28] [29] ; indeed, such interactions between PECAM-1 molecules on the same cell and between cells are believed to underlie most of its identified functions. Additional potential ligand binding interactions have been reported, such as with integrin α v β 3 and CD38 but the functional significance of these is not known 30, 31 . Signal transduction through this receptor is mediated through two Immunoreceptor Tyrosine-based Inhibitory Motifs (ITIMs) 32 , conserved signalling sequences defined by the consensus sequence L/I/V/S/T-x-Y-x-x-L/V, that it shares with a family of inhibitory receptors of the immune system including FcγRIIB and killer inhibitory receptors. The ligand-induced clustering of platelet PECAM-1 24, 25 , platelet activation by collagen and thrombin 33 , and fibrinogen-mediated platelet aggregation 25 result in the tyrosine phosphorylation of the cytoplasmic ITIM motifs 34 . This leads
For personal use only. on . by guest www.bloodjournal.org From to the recruitment of signalling proteins such as the tyrosine phosphatases SHP-1 and SHP-2, which bind to the phosphotyrosine residues via src-homology 2 (SH2) domains 35, 36 . Little is known, particularly in platelets, of what follows, or the identity of substrates for recruited phosphatases, but this leads to the inhibition of activatory signalling mechanisms. 39 .
The aim of this study was therefore to examine in more detail the potential role of PECAM-1 in the regulation of thrombus formation. We have utilised mice that lack the systemic expression of PECAM-1, and chimeric PECAM-1 deficient mice to explore the respective roles of platelet and endothelial PECAM-1 in thrombus formation in vivo. Two distinct in vivo assays of thrombosis were used: a high speed intravital microscopy system that allows real-time analysis of several parameters of laser-induced thrombus formation, and a ferric chloride model of thrombosis with measurement of blood flow using a Doppler flow probe. Our data indicate the involvement of platelet PECAM-1 in the negative regulation of platelet function in vivo.
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MATERIALS AND METHODS

Materials
Antibodies: Rat anti-mouse CD41 was purchased from BD (Palo Alto, CA) and Mouse anti-human fibrin antibody (NYBT2G1) was from Accurate Chemical and Scientific Corporation (Westbury, NY).
Mice: Transgenic PECAM-1 deficient mice were obtained from Dr Tak Mak (Amgen Institute, Toronto, ON, Canada) and bred on a C57BL/6J background at the Biomedical Resource Center at the Medical College of Wisconsin. Control animals were age and gender matched C57BL/6J mice.
Creation of radiation chimeras
Bone marrow cells were harvested from the femurs and tibias of wild-type or PECAM-1-deficient C57BL/6J mice into X-vivo 15 media (Atlanta Biologicals, Norcross, GA). Small mononuclear 
Intravital microscopy
The design and use of a novel intravital microscopy system to analyse thrombus formation in the mouse has been described recently 40 . This model has been shown to stimulate thrombus formation without causing exposure of subendothelial collagens 41 . Briefly, antibodies to murine CD41 were labelled with Alexa-660 or 647 using the Alexa Fluor Protein Labeling kit (Molecular Probes, Mice were anaesthetised with intraperitoneal injection of 125 mg/kg ketamine, 12.5 mg/kg xylazine and 250 µg/kg atropine sulphate. Anaesthesia was maintained with 5 mg/kg Nembutal as required through a jugular vein canula. The cremaster muscle was exteriorised, connective tissue removed, and an incision made to allow the muscle to be affixed as a single sheet over a glass slide. During preparation and throughout the experiment the muscle preparation was hydrated with buffer (135mM NaCl, 4.7mM KCl, 2.7 mM CaCl 2 , 18 mM NaHCO 3 , pH7.4).
Labelled anti-CD41 antibodies (0.1 µg/g bodyweight) were infused through the jugular canulus 10 minutes before beginning induction of the first thrombus. Between 1 and 3 arterioles were visible in each cremaster muscle preparation. Arterioles with undisrupted flow were chosen (estimated shear rate between 800 and 1600 s -1 ) and a number of thrombi were studied tracking up each vessel against the direction of blood flow. Endothelial injury was induced using a pulsed nitrogen dye laser at 440nm that was focussed onto the blood vessel wall through the microscope optics.
Widefield fluorescence (660nm excitation wavelength, 60 ms) and brightfield (40 ms) images were collected alternately for up to 3 minutes after injury formation. For some experiments the accumulation of fibrin and platelets was measured simultaneously. This was achieved by coinfusion of fluorescently labelled anti-CD41 and anti-fibrin (0.5 µg/g bodyweight) antibodies.
Images were taken in rapid repeating sequence to visualise platelets (excitation wavelength 660 nm, 20 ms), and fibrin (excitation wavelength 488 nm, 15 ms) followed by a brightfield image (20 ms).
Data were collected and analysed using the SlideBook imaging software and some graphical analysis using SigmaPlot (SPSS, Chicago, IL). Specifically, thrombus area and integrated thrombus fluorescence were measured over time.
Ferric chloride induced model of thrombosis
7
Ferric chloride induced models of thrombosis have been shown to cause substantial damage to the endothelium and exposure of underlying collagens 41, 42 . The following method was developed by Kurz et al (1990) for use in rats 43 and has been subsequently applied to mouse studies 44, 45 . Adult mice (>8 weeks old, 22-32 g) were anesthetized by intraperitoneal injection of pentobarbital (120 mg/kg). The carotid artery was surgically exposed and sodium chloride solution (0.9%) was placed in the surgical wound. A miniature ultrasound Doppler flowprobe (Model:0.5VB; Transonic Inc., Ithaca, NY) was placed under the artery to record the baseline blood flow using a Transonic Model T106 flowmeter. Afterwards, the sodium chloride was removed from the wound and filter paper (Whatman #4) saturated with 10% ferric chloride was applied for 3 min on the adventitial surface of the artery. After 3 min, the filter paper was removed, the wound was rinsed and saturated with saline solution, and the carotid blood flow was monitored. The blood flow readings were continuous. Time to thrombotic occlusion was defined as the time for the blood flow to drop to 25% of the baseline values.
Statistical analysis
Data were checked for normal distribution using the Shapiro-Wilk normality test and statistical significance determined using the Student's t test. P values ≤0.05 were taken to indicate significant differences.
RESULTS
Thrombi are larger in PECAM-1 deficient mice
The role of PECAM-1 in the inhibition of platelet aggregation and signalling in vitro, has been recently documented 24, 25 . In addition, platelets from PECAM-1 deficient mice have been shown to be hyper-responsive to collagen and to form larger thrombi when flowed over collagen surfaces in vitro, further implicating PECAM-1 in the negative regulation of platelet function 25, 26 . In the present study, intravital microscopy of cremaster muscle arterioles was utilised to study the process of thrombus formation in real-time in normal and PECAM-1-deficient mice.
Thrombus formation was stimulated by laser-induced injury in arterioles in control and PECAM-1-deficient mice and studied in real-time by assessing the accumulation of platelets fluorescently labelled with Alexa-660-conjugated anti-CD41 antibodies into the developing thrombus. With both control and PECAM-1 deficient mice, the degree of correlation between the time of initial thrombus formation and either the amount of time elapsed since the laser was fired, or the duration of laser firing, was variable. Similarly, the rate of thrombus formation and the size and shape of the thrombus formed was variable in mice of different genotypes. Multiple thrombi in up to 6 separate mice were therefore analysed for quantitative differences between control and PECAM-1 deficient mice to be assessed.
Thrombus size was assessed in real-time by measuring the area occupied by the thrombus and integrated thrombus fluorescence. Since thrombus area measurements may be affected by the position of the focal plane during data collection and the orientation of the thrombus within the blood vessel, integrated thrombus fluorescence was incorporated since this may be expected to produce more precise quantitative data. This is a measure of total fluorescence and is proportional to the number of platelets present in a thrombus at a given time.
Blinded analysis of the area occupied by thrombi and integrated thrombus fluorescence over time was performed using SlideBook image analysis software. Thrombus sizes were analysed for up to 160 s following the initiation of thrombus formation, and expressed as plots of thrombus area (µm 2 ) 9 or arbitrary fluorescence levels against time. Median thrombus area and integrated thrombus fluorescence are displayed over a period of 120s following thrombus initiation in Figure 1A .
Thrombus area and integrated fluorescence levels were observed to be larger in the PECAM-1 deficient mice at all time points studied following initiation of thrombus formation (Control: n=14 thrombi; PECAM-1 deficient n=20 thrombi). The profiles of median thrombus area and integrated thrombus fluorescence levels over this time period were similar. As an alternative method of analysis, thrombus area or fluorescence levels were plotted over time and areas under curves calculated. Analysis of mean data indicated that thrombi were significantly larger in PECAM-1 deficient mice (Control: n=11 thrombi; PECAM-1 deficient: n=12 thrombi; P < 0.05).
Analysis of the initial rate of increase in median integrated thrombus fluorescence over the first 40 seconds of thrombus development indicates faster kinetics (approximately double the rate) of initial thrombus growth in the PECAM-1 deficient mice. Similar increased initial kinetics were observed for both integrated fluorescence and thrombus area ( Figure 1A ).
To assess thrombus stability, the duration for which each thrombus remained above 50% of its maximal area or fluorescence intensity was assessed. Mean duration values are shown in Figure 1B and demonstrate significantly greater thrombus stability in PECAM-1 deficient mice. The In PECAM-1 deficient mice, PECAM-1 is absent from platelets and endothelial cells. It was therefore unclear whether the enhanced thrombus formation observed in these mice was due to the 
Time to blood vessel occlusion is decreased in PECAM-1 deficient platelets.
A second model of thrombosis was used in control and PECAM-1 deficient mice. The additional use of the ferric chloride model of thrombosis enabled thrombus formation to be studied in larger vessels and at high flow rates. These assays were also performed blinded for mouse genotype.
Thrombus formation was measured in the carotid artery using an ultrasound Doppler flowprobe, following exposure to ferric chloride solution as described in Materials and Methods. The time to 75% vessel occlusion was measured (i.e. until blood flow was reduced to 25% of baseline value) and results are shown in Figure 4 . The mean time to 75% occlusion (± standard deviation) for PECAM-1-deficient mice was 8.1 ± 1.1 min (n=12), which was significantly shorter (p < 0.03) than that observed in wild-type mice (10.0 ± 2.7 min, n=14). The overall magnitude of differences were modest, with results using this model of thrombosis in several wild type mice appearing comparable to PECAM-1 deficient mice. . PECAM-1 has also been found to inhibit platelet activation stimulated by G protein coupled receptor agonists such as thrombin, albeit to a lesser degree 22 .
In the present study we have employed PECAM-1 deficient mice, to investigate the role of PECAM-1 in thrombus formation in vivo. The use of a highly sensitive intravital microscopic technique to study thrombus formation in real time, and a ferric chloride model of thrombosis, has enabled us to establish a role for this molecule in the regulation of thrombus formation in vivo.
Thrombi formed in cremaster muscle arterioles upon laser injury in PECAM-1 deficient mice were significantly larger than those formed in control mice. Faster kinetics of thrombus formation were observed in the PECAM-1 deficient mice, and the difference in thrombus size appeared constant throughout the time that thrombus development was measured. In addition, thrombi formed in the PECAM-1 knockout mice appeared to have greater stability.
Enhanced thrombus formation in PECAM-1 knockout mice may be due to a lack of PECAM-1 on platelets (and leukocyte), or on endothelial cells, or its absence on both. To address this, laserinduced thrombus formation was examined in chimeric mice generated through bone marrow transplantation. WT mice were transplanted with PECAM-1 deficient bone marrow to examine the potential role for platelet PECAM-1 in the regulation of thrombus formation. In comparison to control mice (WT mice transplanted with WT bone marrow), thrombi formed more rapidly and were larger ( Figure 3B ). The level of enhanced thrombus development was similar to that observed normal bleeding times in PECAM-1 deficient mice 39 . The reason for the discrepancy between these studies is unclear, but is likely to reflect differences in experimental procedures.
Upon damage to the endothelium, coagulation is triggered through the exposure of tissue factor in the blood vessel wall and/or recruitment on circulating microparticles [54] [55] [56] , resulting in thrombin generation and fibrin formation within the thrombus. Fibrin deposition in thrombi was measured simultaneously with platelet accumulation in bone marrow transplantation mice. The levels and rate of fibrin formation in thrombi were found to be very similar between the three mouse types ( Figure 3C ). This indicates that larger thrombi in PECAM-1 deficient mice are due to hyperreactive platelets, rather than enhanced activation of the endothelium or coagulation system.
The laser induced injury model used has been characterised and found to result in insufficient endothelial damage to cause the exposure of subendothelial collagens 41 . This is consistent with Our results implicate PECAM-1 in the negative regulation of platelet function in small cremasteric arterioles, and in carotid arteries. This is consistent with Rosenblum's observation that intravenous injection of anti-PECAM-1 antibodies delayed platelet adhesion and aggregation in mice, using a
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From photochemical model of thrombosis shown not to denude the endothelium 37, 38 . Interference by anti-PECAM-1 antibodies in platelet adhesion /aggregation at sites of injury was proposed to underlie this effect, although we would suggest this may have been due to the stimulation of PECAM-1 signalling rather than the inhibition of adhesive interactions.
In most models of thrombosis the mechanism of thrombus formation is not well characterised. This has repercussions in the comparison of data produced using different thrombosis models, and potential inconsistencies between studies. For example our data differ from those of Vollmar et al.
who reported a lack of function of PECAM-1 in photochemically-induced vascular thrombosis in cremasteric vessels 39 . Their inability to detect any differences in the PECAM-1 deficient mice probably reflects the different experimental systems employed, methods of detection and analysis, and lower sensitivity. It is also possible that different in vivo models of thrombosis may produce different results depending on the combination of pro-thrombotic factors and/or negative regulators that are exposed, released or generated. Given this, it is possible that the role of PECAM-1 in vivo may also be dependent on the nature of an injury and the activatory factors present, between healthy or diseased vessels and the position of platelets within a thrombus.
We have speculated previously that the ligation and thereby oligomerisation of PECAM-1 between platelets and endothelial cells at the periphery of a developing thrombus may prevent platelet activation and therefore limit the spread and size of the developing thrombus 24 . It has also been FeCl 3 were applied to exposed carotid arteries for three minutes to induce acute injury to the endothelium, after which the vessels were rinsed and saturated with saline solution. Blood flow was monitored with a miniature Ultrasound Doppler flowprobe placed under the exposed artery and recorded using a Transonic Model T106 flowmeter. The time for blood flow to drop to 25% of baseline values (75% occlusion) was determined. Each data point reflects the time for the left carotid artery to become 75% occluded in PECAM-1-deficient (left) or wild-type (right) animals.
The solid line through each data set represents the mean time to 75% occlusion ± standard deviations. The mean time to 75% occlusion (± standard deviation) for PECAM-1-deficient mice was 8.1 ± 1.1 (n=12), which was significantly shorter (p < 0.03) than that observed in wild-type mice (10.0 ± 2.7, n=14).
For Time to 75% Occlusion (min)
